128 related articles for article (PubMed ID: 36334633)
1. Mutations in the α4-α5 allosteric lobe of RAS do not significantly impair RAS signaling or self-association.
Whaby M; Wallon L; Mazzei M; Khan I; Teng KW; Koide S; O'Bryan JP
J Biol Chem; 2022 Dec; 298(12):102661. PubMed ID: 36334633
[TBL] [Abstract][Full Text] [Related]
2. Targeting the α4-α5 interface of RAS results in multiple levels of inhibition.
Spencer-Smith R; Li L; Prasad S; Koide A; Koide S; O'Bryan JP
Small GTPases; 2019 Sep; 10(5):378-387. PubMed ID: 28692342
[TBL] [Abstract][Full Text] [Related]
3. Targeting the α4-α5 dimerization interface of K-RAS inhibits tumor formation in vivo.
Khan I; Spencer-Smith R; O'Bryan JP
Oncogene; 2019 Apr; 38(16):2984-2993. PubMed ID: 30573767
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of RAS function through targeting an allosteric regulatory site.
Spencer-Smith R; Koide A; Zhou Y; Eguchi RR; Sha F; Gajwani P; Santana D; Gupta A; Jacobs M; Herrero-Garcia E; Cobbert J; Lavoie H; Smith M; Rajakulendran T; Dowdell E; Okur MN; Dementieva I; Sicheri F; Therrien M; Hancock JF; Ikura M; Koide S; O'Bryan JP
Nat Chem Biol; 2017 Jan; 13(1):62-68. PubMed ID: 27820802
[TBL] [Abstract][Full Text] [Related]
5. Targeting the KRAS α4-α5 allosteric interface inhibits pancreatic cancer tumorigenesis.
Khan I; Marelia-Bennet C; Lefler J; Zuberi M; Denbaum E; Koide A; Connor DM; Broome AM; Pécot T; Timmers C; Ostrowski MC; Koide S; O'Bryan JP
Small GTPases; 2022 Jan; 13(1):114-127. PubMed ID: 33949915
[No Abstract] [Full Text] [Related]
6. Membrane-associated Ras dimers are isoform-specific: K-Ras dimers differ from H-Ras dimers.
Jang H; Muratcioglu S; Gursoy A; Keskin O; Nussinov R
Biochem J; 2016 Jun; 473(12):1719-32. PubMed ID: 27057007
[TBL] [Abstract][Full Text] [Related]
7. Two Distinct Structures of Membrane-Associated Homodimers of GTP- and GDP-Bound KRAS4B Revealed by Paramagnetic Relaxation Enhancement.
Lee KY; Fang Z; Enomoto M; Gasmi-Seabrook G; Zheng L; Koide S; Ikura M; Marshall CB
Angew Chem Int Ed Engl; 2020 Jun; 59(27):11037-11045. PubMed ID: 32227412
[TBL] [Abstract][Full Text] [Related]
8. Crystal Structure Reveals the Full Ras-Raf Interface and Advances Mechanistic Understanding of Raf Activation.
Cookis T; Mattos C
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356620
[TBL] [Abstract][Full Text] [Related]
9. Is Nanoclustering essential for all oncogenic KRas pathways? Can it explain why wild-type KRas can inhibit its oncogenic variant?
Nussinov R; Tsai CJ; Jang H
Semin Cancer Biol; 2019 Feb; 54():114-120. PubMed ID: 29307569
[TBL] [Abstract][Full Text] [Related]
10. Millisecond molecular dynamics simulations of KRas-dimer formation and interfaces.
Ngo VA; Garcia AE
Biophys J; 2022 Oct; 121(19):3730-3744. PubMed ID: 35462078
[TBL] [Abstract][Full Text] [Related]
11. Allosteric site variants affect GTP hydrolysis on Ras.
Johnson CW; Fetics SK; Davis KP; Rodrigues JA; Mattos C
Protein Sci; 2023 Oct; 32(10):e4767. PubMed ID: 37615343
[TBL] [Abstract][Full Text] [Related]
12. Multivalent assembly of KRAS with the RAS-binding and cysteine-rich domains of CRAF on the membrane.
Fang Z; Lee KY; Huo KG; Gasmi-Seabrook G; Zheng L; Moghal N; Tsao MS; Ikura M; Marshall CB
Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12101-12108. PubMed ID: 32414921
[TBL] [Abstract][Full Text] [Related]
13. GTP-Dependent K-Ras Dimerization.
Muratcioglu S; Chavan TS; Freed BC; Jang H; Khavrutskii L; Freed RN; Dyba MA; Stefanisko K; Tarasov SG; Gursoy A; Keskin O; Tarasova NI; Gaponenko V; Nussinov R
Structure; 2015 Jul; 23(7):1325-35. PubMed ID: 26051715
[TBL] [Abstract][Full Text] [Related]
14. α4-α5 Helices on Surface of KRAS Can Accommodate Small Compounds That Increase KRAS Signaling While Inducing CRC Cell Death.
Abuasaker B; Garrido E; Vilaplana M; Gómez-Zepeda JD; Brun S; Garcia-Cajide M; Mauvezin C; Jaumot M; Pujol MD; Rubio-Martínez J; Agell N
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614192
[TBL] [Abstract][Full Text] [Related]
15. Ras-GTP dimers activate the Mitogen-Activated Protein Kinase (MAPK) pathway.
Nan X; Tamgüney TM; Collisson EA; Lin LJ; Pitt C; Galeas J; Lewis S; Gray JW; McCormick F; Chu S
Proc Natl Acad Sci U S A; 2015 Jun; 112(26):7996-8001. PubMed ID: 26080442
[TBL] [Abstract][Full Text] [Related]
16. TC21 causes transformation by Raf-independent signaling pathways.
Graham SM; Vojtek AB; Huff SY; Cox AD; Clark GJ; Cooper JA; Der CJ
Mol Cell Biol; 1996 Nov; 16(11):6132-40. PubMed ID: 8887643
[TBL] [Abstract][Full Text] [Related]
17. Galectin-1 dimers can scaffold Raf-effectors to increase H-ras nanoclustering.
Blaževitš O; Mideksa YG; Šolman M; Ligabue A; Ariotti N; Nakhaeizadeh H; Fansa EK; Papageorgiou AC; Wittinghofer A; Ahmadian MR; Abankwa D
Sci Rep; 2016 Apr; 6():24165. PubMed ID: 27087647
[TBL] [Abstract][Full Text] [Related]
18. RAS ubiquitylation modulates effector interactions.
Thurman R; Siraliev-Perez E; Campbell SL
Small GTPases; 2020 May; 11(3):180-185. PubMed ID: 29185849
[TBL] [Abstract][Full Text] [Related]
19. Quaternary organization of the goodpasture autoantigen, the alpha 3(IV) collagen chain. Sequestration of two cryptic autoepitopes by intrapromoter interactions with the alpha4 and alpha5 NC1 domains.
Borza DB; Bondar O; Todd P; Sundaramoorthy M; Sado Y; Ninomiya Y; Hudson BG
J Biol Chem; 2002 Oct; 277(42):40075-83. PubMed ID: 12193605
[TBL] [Abstract][Full Text] [Related]
20. Peptides containing a consensus Ras binding sequence from Raf-1 and theGTPase activating protein NF1 inhibit Ras function.
Clark GJ; Drugan JK; Terrell RS; Bradham C; Der CJ; Bell RM; Campbell S
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1577-81. PubMed ID: 8643674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
